Delivery Order SPE2DR25D3005-SPE2DR26FP7MX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of INFANRIX DTAP Syringe 0.5mL, a pediatric diphtheria, tetanus, and acellular pertussis vaccine. This firm fixed-price delivery order, valued at $3,091.60, represents a small-value pharmaceutical procurement supporting military and federal healthcare systems. The award is non-competitive and utilizes no set-aside designation, indicating fulfillment through an existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,023.35 to AmerisourceBergen Drug Corp for INFANRIX DTAP SYRINGE 0.5ML, a diphtheria, tetanus, and pertussis vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of October 30, 2025, and was awarded on October 29, 2025. This award represents a non-set-aside competitive contract, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,918.05 to AmerisourceBergen Drug Corp for INFANRIX DTAP Syringe 0.5ML on December 26, 2025, with completion expected by December 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Infanrix DTAP Syringe 0.5ML, a pediatric vaccine product, with a contract value of $1,391.22. The award was made on August 19, 2025, with an ultimate completion date of August 20, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a $1,837.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for Infanrix DTaP vaccine in 0.5 mL syringe format. This is a non-set-aside competitive award with performance location in Conshohocken, Pennsylvania, and an ultimate completion date of January 23, 2026. The delivery order represents a single task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $1,913.65 delivery order to AmerisourceBergen Drug Corp for INFANRIX DTAP vaccine syringes (0.5mL) with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Infanrix DTAP syringes (0.5 mL) with a ceiling value of $7,231.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The order is scheduled for ultimate completion by September 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,503.70 to AmerisourceBergen Drug Corp for the supply of Infanrix DTaP syringes (0.5mL) under a firm fixed price contract. The award was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, and carries no set-aside designation. Performance will take place in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a competitive award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,178.09 to supply 0.5ML DAPTACEL DTAP vaccine, with an ultimate completion date of December 24, 2025. This is a firm fixed-price delivery order issued under no set-aside program, reflecting competitive procurement practices. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFANRIX DTAP vaccine syringes. The contract has a ceiling value of $1,363.72 and a period of performance through January 28, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP7MXDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,430.70 for INFANRIX DTAP syringe 0.5ML, a standard diphtheria, tetanus, and acellular pertussis vaccine product. The award was made on November 26, 2025, with an ultimate completion date of November 28, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. The contract will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime vendor agreement enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including vaccines, medications, medical devices, and specialized healthcare commodities. The company is a major pharmaceutical distributor and critical federal vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/25/25 |